Efavirenz use during pregnancy and for women of child-bearing potential

<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews e...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Gray Glenda E, Krause Amanda, Wessels Tina, Venter Francois WD, Urban Michael F, Chersich Matthew F, Luchters Stanley, Viljoen Dennis L
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2006-04-01
Saila:	AIDS Research and Therapy
Sarrera elektronikoa:	http://www.aidsrestherapy.com/content/3/1/11
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!